Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Carboplatin Plus Vincristine in Treating Children With Retinoblastoma
This study is ongoing, but not recruiting participants.
Study NCT00002794 Information provided by National Cancer Institute (NCI)
First Received: November 1, 1999 Last Updated: August 23, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Retinoblastoma
More general conditions related to this trial
Eye Diseases
Eye Neoplasms
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial
Neuroectodermal Tumors
Retinal Diseases
Retinal Neoplasms
Interventions listed in this trial
carboplatin
vincristine sulfate
Additional drug interventions recognized in this trial
Vincristine
More general drug interventions related to this trial
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
Back to top of Main Content
